AAP
IRON icon

Arax Advisory Partners’s Disc Medicine IRON Stock Holding History

Arax Advisory Partners’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.29K Buy
+86
New +$5.91K ﹤0.01% 4532
2026
Q1 		– Sell
-2
Closed -$159 – 4069
2025
Q4 		$159 Sell
2
-204
-99% -$17.2K ﹤0.01% 3760
2025
Q3 		$13.6K Buy
+206
New +$12.3K ﹤0.01% 2464

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Arax Advisory Partners's IRON Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Disc Medicine (IRON) in Q2 2026: 86 shares worth $6.29K. The stake represents ﹤0.01% of the portfolio and ranks #4532 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in IRON as recently as Q4 2025.

Arax Advisory Partners first reported a position in IRON in Q3 2025 and has held it in 3 quarters since. The position peaked at $13.6K in Q3 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Arax Advisory Partners held 86 shares of Disc Medicine worth $6.29K as of Q2 2026.
  • Disc Medicine was a new Arax Advisory Partners position in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4532 holding.
  • Arax Advisory Partners first reported a position in Disc Medicine in Q3 2025 and has held it in 3 quarters since.
  • Arax Advisory Partners's Disc Medicine position peaked at $13.6K in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.